Clinical Trial Management - software & AI news

Daily news on software, AI, and companies shaping clinical trial management.

Showing 118 results
Press release cover image

Oct 22, 2026

Boehringer Ingelheim and Microsoft partner to drive patient-centric and AI-backed clinical development

Two strong partners aim to accelerate AI-enabled clinical developmentBuilding a foundation for Digital Patient Twins to bring safe and effective therapies to patients soonerPotential co-development of projects in Animal Health and business functions Cologne, Germany - Boehringer Ingelheim and Microsoft today announced a strategic collaboration that aims to bring safe and effective therapies to patients sooner fueled by AI. The collaboration will focus on jointly investigating the potential of Di
Press release cover image

Oct 21, 2026

Right2Hope Launches Free Cancer Treatment Search Platform to Help Patients Explore Investigational Therapies

Nonprofit resource helps advanced cancer patients and oncologists find experimental treatments to explore via expanded access and Right to TryDALLAS, Oct. 21, 2026 /PRNewswire/ -- For patients with advanced cancer who have exhausted standard treatment options, the hardest question is often: What else is out there?Today, nonprofit Right2Hope launched www.right2hope.org, a free online platform that helps patients, families, and oncologists identify investigational cancer therapies worth exploring
A minimalist illustration of a syringe symbolizing clinical trials.

Oct 21, 2026

Oracle and AstraZeneca to collaborate on 'smarter' clinical trials

AstraZeneca and Oracle Health have announced a partnership aimed at enhancing clinical trial processes through artificial intelligence (AI), addressing significant challenges in patient safety and recruitment.The collaboration seeks to develop a continuous learning model that leverages insights from both clinical research and routine healthcare. By utilizing real-world data, the initiative aims to identify eligible patients for clinical trials more effectively, thus streamlining the research pro
A laboratory flask with a biological sample on a lab bench

Oct 21, 2026

OpenAI acquired biotech startup Orchestra Bio to expand its life sciences AI tools

OpenAI has acquired Orchestra Bio, a biotechnology startup, to enhance its life sciences AI capabilities through integration into its existing Rosalind platform.This acquisition involves the incorporation of Orchestra's technology and team into Rosalind, OpenAI's suite of AI models designed for life sciences research. Although the financial details of the deal remain undisclosed, the merger is expected to bolster OpenAI's efforts in streamlining the research process. Orchestra's platform allows
Press release cover image

Oct 21, 2026

Optum and Syneos Health Partner to Advance an Adaptive Clinical Development Model

Partnership Will Transform How Clinical Development is Designed and Executed MORRISVILLE, N.C., Oct. 20, 2026 (GLOBE NEWSWIRE) -- Syneos Health® today announced a partnership with Optum to build a more adaptive and connected model for clinical development, helping biopharmaceutical companies deliver promising therapies to patients sooner. The collaboration will bring together Optum’s healthcare industry knowledge, specialized expertise and AI resources with Syneos Health’s clinical development
A clipboard with clinical trial metrics on a desk in an office setting.

Oct 20, 2026

Advocacy organization launches data dashboard to better assess how clinical trial sites perform

The Society for Clinical Research Sites (SCRS) has introduced a new data intelligence tool, the Eagle Insights Dashboard, designed to enhance the evaluation of clinical trial site performance.This innovative platform allows clinical trial sponsors and Contract Research Organizations (CROs) to assess their effectiveness through a comprehensive scoring system. The score aggregates various metrics, including study start-up efficiency, communication quality, and the diversity of patient populations.
A minimalist illustration of a patient and a magnifying glass representing clinical trial recruitment.

Oct 20, 2026

AstraZeneca taps Oracle to help improve recruitment for clinical trials

AstraZeneca collaborates with Oracle to enhance clinical trial recruitment efficiency, addressing a long-standing challenge in drug development.The partnership, established through a non-binding agreement, aims to leverage advanced applications and AI to streamline the clinical trial process. This collaboration is particularly focused on improving the early identification of eligible patients across various disease areas, including oncology, rare diseases, cardiovascular, renal, metabolic, respi
Press release cover image

Oct 19, 2026

Clinical ink Announces Strategic Investment from Ardan Equity and GI Partners to Accelerate Next Phase of Growth

Ardan and GI to bring deep, complementary domain expertise across life sciences and healthcare technology and partner with management to further accelerate Clinical ink's growth WINSTON-SALEM, N.C., Oct. 19, 2026 /PRNewswire/ -- Clinical ink, a global clinical trial technology company, today announced investments from Ardan Equity ("Ardan"), a private equity firm specializing in healthcare technology, through Ardan Equity Fund I and from GI Partners ("GI"), a leading private investment firm that
Press release cover image

Oct 15, 2026

SCRS Launches The Eagle Insights Dashboard, an Industry-First Data Intelligence Platform Giving Sponsors and CROs a Clearer Path to Stronger Site Relationships

New benchmarked site intelligence platform equips pharmaceutical sponsors and CROs with insights to identify and close the gaps holding back site engagementORLANDO, Fla., Oct. 15, 2026 /PRNewswire/ -- The Society for Clinical Research Sites (SCRS), the leading global organization dedicated to advancing the interests of clinical research sites, today announced the launch of The Eagle Insights Dashboard at the SCRS Global Site Solutions Summit. The Eagle Insights Dashboard is an industry-first dat
Press release cover image

Oct 15, 2026

Nabla Integrates with OpenEvidence to Deliver Clinical Evidence at the Point of Care

New integration brings clinical decision support into the encounter workflow, connecting patient context with evidence-based guidance to help clinicians make informed decisionsNEW YORK, Oct. 15, 2026 /PRNewswire/ -- Nabla, one of the most widely adopted AI assistants in clinical care, today announced an integration with OpenEvidence, the leading AI-powered clinical decision support platform, making trusted medical evidence accessible within Nabla.Continue Reading Clinical docume
Press release cover image

Oct 14, 2026

Cumulus Neuroscience and Transpharmation Partner to Carry Objective EEG Measurement from Preclinical Research into First-in-Human Studies

The two companies will work jointly with biopharma sponsors to provide a bridge between pre-clinical work and first-in-human studies, aligning quantitative EEG and cognitive endpoints across species so that a single objective measure of brain function follows a molecule from animal models into first-in-human trials. A cross-species analysis presented by the partners in February 2026 showed a conserved ketamine EEG signature in mouse, rat, dog, and human.BELFAST, Northern Ireland and LONDON, Oct.
Press release cover image

Oct 13, 2026

Suvoda makes Sofia AI assistant available for clinical trials to drive faster answers and action

Key TakeawaysClinical trials require guard railed AI that's purpose built for the regulated industry that has high human stakes and required audit trails.Sofia helps make complex, fast-moving trial data more accessible to study teams who manage large volumes of time-sensitive work.Study teams can get faster answers and take confident action. Sofia goes beyond information retrieval and can execute authorized system actions on behalf of busy users while maintaining the permissions and audit trails